Osuna-Padilla Iván Armando, Rodríguez-Moguel Nadia Carolina, Aguilar-Vargas Adriana, Tolentino-Dolores Maricruz, Perichart-Perera Otilia, Ahumada-Topete Victor, Ávila-Ríos Santiago, Soto-Nava Maribel, Diaz-Rivera Dafné, De León-Lara Enrique, Wilson-Verdugo Marti, Briceño Olivia
Coordinación de Nutrición Clínica, Departamento de Áreas Críticas, Instituto Nacional de Enfermedades Respiratorias "Ismael Cosío Villegas", Mexico City, Mexico.
Centro de Investigación en Enfermedades Infecciosas, Instituto Nacional de Enfermedades Respiratorias "Ismael Cosío Villegas", Mexico City, Mexico.
Front Nutr. 2024 Sep 16;11:1417975. doi: 10.3389/fnut.2024.1417975. eCollection 2024.
Deficiency of zinc and selenium is common in persons living with human immunodeficiency virus (PLWHIV) and has been associated with the development of non-AIDS related comorbidities, impaired immune system function and mortality. Micronutrient supplementation on long-term-treated PLWHIV could bring potential clinical and immunological benefits improving their health status and quality of life. The aim of the present study is to analyze the effect of zinc and selenium supplementation on body composition, bone mineral density, CD4+ T-cell counts, metabolic profile and immune system status on clinical stable PLWHIV on long-term antiretroviral therapy (ART).
This is a randomized pilot clinical trial in which we recruited 60 PLWHIV on ART who were assigned to the intervention groups: zinc (30 mg of zinc gluconate), selenium (200 μg of selenium yeast), zinc + selenium (same doses and presentations) or to a control group (without nutritional supplementation) who received supplementation during 6 months. Primary outcome was defined as changes in body composition (weight, muscle and fat mass and bone mineral density) and secondary outcomes as changes in biochemical and immunological parameters (CD4+ T-cell count, cholesterol, glucose, triglycerides and seric zinc and selenium seric concentrations) before and after supplementation. Peripheral blood mononuclear cells (PBMCs) of one individual of each intervention group were analyzed for single cell transcriptomics before and after supplementation.
BMI ( = 0.03), fat mass ( = 0.03), and trunk fat ( = 0.01) decreased after 6 months of selenium supplementation. No changes were observed for cholesterol, glucose or triglycerides after supplementation ( > 0.05 in all cases). CD4+ T cells percentage increased after 6 months of selenium supplementation ( = 0.03). On the transcriptome analysis, zinc and selenium supplementation induced changes on de expression of genes associated with the function of naive and memory CD8+ T-cells ( < 0.05 in all cases).
Zinc and selenium supplementation could represent a complementary intervention that may improve the health status and immune response of treated PLWHIV.
锌和硒缺乏在人类免疫缺陷病毒感染者(PLWHIV)中很常见,并且与非艾滋病相关合并症的发生、免疫系统功能受损及死亡率有关。对长期接受治疗的PLWHIV进行微量营养素补充可能会带来潜在的临床和免疫学益处,改善他们的健康状况和生活质量。本研究的目的是分析补充锌和硒对长期接受抗逆转录病毒治疗(ART)的临床稳定的PLWHIV的身体成分、骨矿物质密度、CD4+T细胞计数、代谢谱和免疫系统状态的影响。
这是一项随机试点临床试验,我们招募了60名接受ART治疗的PLWHIV,将其分配到干预组:锌(30毫克葡萄糖酸锌)、硒(200微克硒酵母)、锌+硒(相同剂量和剂型)或对照组(不进行营养补充),为期6个月。主要结局定义为补充前后身体成分(体重、肌肉和脂肪量以及骨矿物质密度)的变化,次要结局为补充前后生化和免疫学参数(CD4+T细胞计数、胆固醇、葡萄糖、甘油三酯以及血清锌和硒浓度)的变化。对每个干预组的一名个体的外周血单个核细胞(PBMC)在补充前后进行单细胞转录组学分析。
补充硒6个月后,体重指数(=0.03)、脂肪量(=0.03)和躯干脂肪(=0.01)下降。补充后胆固醇、葡萄糖或甘油三酯未见变化(所有情况下均>0.05)。补充硒6个月后CD4+T细胞百分比增加(=0.03)。在转录组分析中,补充锌和硒诱导了与初始和记忆CD8+T细胞功能相关基因的表达变化(所有情况下均<0.05)。
补充锌和硒可能是一种补充性干预措施,可改善接受治疗的PLWHIV的健康状况和免疫反应。